Cardinal Health (CAH) : Analyst Rating Update

Cardinal Health (CAH) : 6 brokerage houses believe that Cardinal Health (CAH) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. 6 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Cardinal Health (CAH). Zacks Investment Research suggests a Sell with a rank of 4.The median of all the 13 Wall Street Analysts endorse the stock as a Buy with a rating of 2.

Cardinal Health (CAH) : The most positive equity analysts on Cardinal Health (CAH) expects the shares to touch $111, whereas, the least positive believes that the stock will trade at $83 in the short term. The company is covered by 11 Wall Street Brokerage Firms. The average price target for shares are $93.18 with an expected fluctuation of $8.65 from the mean.

Cardinal Health (NYSE:CAH): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $78.18 and $77.77 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $80.47. The buying momentum continued till the end and the stock did not give up its gains. It closed at $79.99, notching a gain of 2.25% for the day. The total traded volume was 2,853,019 . The stock had closed at $78.23 on the previous day.

Also, Major Brokerage house, Bank of America reinstates its ratings on Cardinal Health (NYSE:CAH). According to the latest information available, the shares are now rated Neutral by the analysts at the agency. The rating by the firm was issued on June 7, 2016. The company shares have dropped -6.20% from its 1 Year high price. On Dec 29, 2015, the shares registered one year high at $91.23 and the one year low was seen on Jun 27, 2016. The 50-Day Moving Average price is $77.67 and the 200 Day Moving Average price is recorded at $81.01.

Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.